Risk stratification in cardiomyopathy
Why the study?
Prognostic stratification is a cornerstone for the management of cardiomyopathies, but data on cardiopulmonary exercise testing for risk stratification across different cardiomyopathies warrant review.
Does cardiopulmonary exercise testing improve risk stratification in patients with cardiomyopathy?
Population
Patients with cardiomyopathies and heart failure
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May refine cardiomyopathy risk stratification via CPET-integrated scores; leaves open prospective validation before routine use.
Structured PICO
Does cardiopulmonary exercise testing improve risk stratification in patients with cardiomyopathy?
P
Population
Patients with cardiomyopathies (including hypertrophic, dilated, arrhythmogenic, and restrictive) and heart failure
I
Intervention
Cardiopulmonary exercise testing (CPET) for risk stratification
O
Outcome
Prognostic stratification for arrhythmic events and heart failure
Cardiopulmonary exercise testing provides valuable prognostic parameters that improve risk stratification in patients with cardiomyopathies and should be routinely performed in advanced heart failure centers.
Cite This Study
Sinagra et al. (2020) studied this question.